Breadcrumb

  1. Home
  2. March 1, 2022 Meeting of the Iowa Board of Pharmacy

March 1, 2022 Meeting of the Iowa Board of Pharmacy

Meeting Time
-
Meeting Location

Iowa Board of Pharmacy
400 SW 8th St
Ste E
Des Moines, IA 50309
United States

Meeting Agenda

Meeting Agenda: 

The March Board meeting has been condensed into a one day meeting and will be held Tuesday, March 1, 2022.

Meeting Location: The meeting will be held via Zoom and in-person at the Board of Pharmacy office.  To access the meeting, see details below:

Join Zoom Meeting:
https://zoom.us/join
Meeting ID: 871 4399 3715
Passcode: MisLy0
One tap mobile
312-626-6799, 87143993715#,*410414# US (Chicago)

Face masks are recommended for all in-person attendees and required for those who are unvaccinated

If you have a fever, cough, shortness of breath or have been exposed to someone with COVID-19 please attend remotely via Zoom.

9:00 a.m. Call to Order, Roll Call, and Announcements

Public Comment Period—anyone who has submitted material for the agenda will be given an opportunity to address the Board during the particular agenda item.  A member of the public wishing to address the Board regarding a particular agenda item should raise a hand during that agenda item to be recognized. During the initial public comment period, members of the public will have the opportunity to address the Board regarding any items not on the agenda, or any agenda item if the person is unable to be present for the discussion of the particular agenda item. Acknowledgment and an opportunity to speak will be limited to 5 minutes per person, with additional time allowed at the discretion of the chairperson.

Approval of Minutes

  1. January 11, 2022 Open Session Minutes

AlixaRx’s Innovative Pharmacy Pilot Project Quarterly Report

Requests

  1. Request to waive 657 IAC 17.3(1)"c" requiring evidence of current drug distributor accreditation as a condition of licensure - Summit SD, LLC, Wholesale Distributor license applicant, Lee's Summit, MO
  2. Request to waive 657 IAC 43.3(1) requiring evidence of current drug distributor accreditation as a condition of licensure - DHL Supply Chain, Third-Party Logistics Provider license applicant, Knoxville, TN
  3. Request to waive 657 IAC 20.24(1) requiring the reporting of interstate distribution of compounded preparations to the NABP Information Sharing Network by April 1 - UnityPoint at Home, Pharmacy license 11, Urbandale
  4. Request to waive 657 IAC 6.2 requiring the pharmacy to have a pharmacist in charge - Walgreens Pharmacy, Pharmacy license 83, Davenport
  5. Request pursuant to 657 IAC 2.12(6)(a) for credit for health-related graduate studies - Alec Gates, Pharmacist license 23877, Raleigh, NC
  6. Request to waive 657 IAC 13.11(1) requiring the completion of 2,000 hours of experience as a certified pharmacy technician for a telepharmacy technician - Nightingale Drug, Pharmacy license 1632, Postville
  7. Request to waive 657 IAC 13.16(4) requiring a telepharmacy site to be located at a distance of at least ten miles from the closest pharmacy that dispenses prescriptions to outpatients - Medicap Pharmacy 1498, Dallas Center

Petition for Exemption from the Mandate for Electronic Transmission of Prescriptions

  1. Springfield Clinic, LLP
  2. Emma Goldman Clinic
  3. Dr. Claudia Addy, DPM
  4. Jill Webb, ARNP

Licensure/Registration Applications

  1. Lindsey Collett, RPh, Pharmacist License Applicant, Milford, IA

Reports & Informational Items

  1. Executive Director’s Report
  2. Meetings and Travel
  3. Prescription Monitoring Program (PMP) Update
  4. Board-Sponsored Medication Disposal Update
  5. Iowa Monitoring Program for Pharmacy Professionals (IMP3) Update
  6. Compliance Report
  7. Update on USP 797/795 Revision Process
  8. 50 Year Pharmacists
  9. APhA Pharmacist Well-Being Index: NABP District V

Rules and Legislation

  1. Legislative Update
  2. Proposed for adoption and filing to amend Chapter 10, "Controlled Substances", to temporarily place one substance into schedule I of the Iowa CSA in response to similar action taken by the federal Drug Enforcement Administration (ARC 6082C)
  3. Proposed for adoption and filing to amend Chapter 13, "Telepharmacy Practice", to reduce the notification period to terminate a written agreement between a managing pharmacy and a telepharmacy site from 90 days to 45 days, authorize the practice of pharmacy support persons at a telepharmacy site and establish training and education requirements, remove duplicated rules found in other Board chapters, and authorize the Board to establish a committee to consider requests for exemption to the technician practice experience requirements in exceptional circumstances that may otherwise result in the closure of a telepharmacy site (ARC 6083C)
  4. Proposed for notice of intended action to amend Chapter 12, "Precursor Substances", to temporarily add one chemical as a precursor substance in Iowa Code in response to similar action taken by the federal Drug Enforcement Administration
  5. Proposed for notice of intended action to amend Chapter 3, "Pharmacy Technicians," and Chapter 6, "General Pharmacy Practice", to provide for pharmacist delegation of technical functions relating to prescription processing activities to an Iowa-registered certified pharmacy technician who is performing the delegated functions at a location other than where the supervising pharmacist is physically located under specific conditions that provide for adequate security and supervision, real-time access between personnel and processing systems, and documentation of functions performed
  6. Proposed for notice of intended action to amend Chapter 8, "Universal Practice Standards," and Chapter 19, "Nonresident Pharmacy Practice", to modify the handling of ownership changes for resident and nonresident pharmacies, provide a requirement that nonresident pharmacies which directly dispense to Iowa patients provide evidence of a toll-free telephone number on prescription labels to provide access to a pharmacist who has access to the patient's records during the pharmacy's regular business hours, and identify the process by which a pharmacy can temporarily relocate pharmacy operations in response to an exceptional circumstance or disaster rending the pharmacy unsafe
  7. Proposed Response or Comment to Proposed FDA Regulation - National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers

Closed Session Agenda—these agenda items will be handled in closed session. For closed session agenda items requiring final action, the Board will vote on these items in open session.

Motion to go into closed session pursuant to Iowa Code section 21.5(1)(a), to review or discuss records which are required or authorized by state or federal law to be kept confidential; pursuant to Iowa Code section 21.5(1)(d), to discuss whether to initiate licensee disciplinary investigations or proceedings; and pursuant to Iowa Code section 21.5(1)(f), to discuss the decision to be rendered in a contested case conducted according to the provisions of Iowa Code chapter 17A.

  1. Review of Closed Session Minutes – 21.5(1)(a)
    1. January 11, 2022 Closed Session Minutes
  2. Complaints and Investigative Reports – 21.5(1)(d)
  3. Notice of Hearing and Statement of Charges – 21.5(1)(d)
  4. Settlement Agreement and Final Orders – 21.5(1)(f)
    1. 2021-0217 Katelynn Parmer, Technician Trainee, Registration 31984, Decatur
  5. Combined Statement of Charges, Settlement Agreement and Final Orders – 21.5(1)(d) & (f)

Return to Open Session

Votes on any closed session agenda items requiring final action

Adjournment

Meeting Minutes Document